Clinical Trial

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Name: Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies — clinical trial record (NCT07240974)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, single-arm, open-label, dose-escalation, early-phase 1 study to evaluate the safety, tolerability and preliminary efficacy of ZZSW-01 injection in patients with relapsed/refractory B-cell malignancies.

Trial Details

NCT Number	NCT07240974
Lead Sponsor	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions	Relapsed/Refractory B-cell Malignancies
Enrollment	6 participants
Start Date	2025-10-28
Primary Completion	2028-09-15 (estimated)
Study Completion	2028-09-15 (estimated)
Updated on ClinicalTrials.gov	2025-11-21